RNXT 8-K 2026-07-02

RenovoRx, Inc. (RNXT) 8-K dated 2026-07-02 — accession 0001493152-26-031662. This URL is the filing, not the RNXT hub.

RenovoRx, Inc. (RNXT) is a biotechnology company listed on US.

RenovoRx, Inc. filed a 8-K on 2026-07-02. Accession 0001493152-26-031662.

Cached items: 3.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNXT revenue for 2026-06-30 was $1.5M. Net income was -$6.4M. RNXT currently screens at market cap $47.0M.

Not investment advice. The RNXT SEC hub lists recent forms. The stock page is the research view.